533 related articles for article (PubMed ID: 10379467)
21. [Clinical application of cyclooxygenase-2 inhibitors].
Dzielska-Olczak M; Olczak S
Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
[TBL] [Abstract][Full Text] [Related]
22. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Tishler M; Langevetiz P; Nesher G
Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
[No Abstract] [Full Text] [Related]
23. New directions in cyclooxygenase research and their implications for NSAID-gastropathy.
Flower RJ
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():23-7. PubMed ID: 9032578
[TBL] [Abstract][Full Text] [Related]
24. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors].
Miehle W
Wien Med Wochenschr; 1999; 149(19-20):541-5. PubMed ID: 10637962
[TBL] [Abstract][Full Text] [Related]
25. [COX-2 inhibitors: a new treatment in rheumatic diseases].
Puddu G; Cravero E
Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282
[TBL] [Abstract][Full Text] [Related]
26. The unmet anti-inflammatory needs in orthopedics.
Trippel SB
Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):3-7. PubMed ID: 10193996
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations.
Lazzaroni M; Bianchi Porro G
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():48-58. PubMed ID: 15335413
[TBL] [Abstract][Full Text] [Related]
28. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
29. Practical implications of cyclooxygenase-2--specific inhibitors in orthopedics.
Marshall KW
Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):19-21. PubMed ID: 10193999
[TBL] [Abstract][Full Text] [Related]
30. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
31. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
Wallace JL; Chapman K; McKnight W
Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen.
Bjarnason I; Macpherson A; Rotman H; Schupp J; Hayllar J
Scand J Gastroenterol; 1997 Feb; 32(2):126-30. PubMed ID: 9051872
[TBL] [Abstract][Full Text] [Related]
33. Gastroduodenal tolerability of highly specific cyclo-oxygenase-2 inhibitor.
Hayllar J; Bjarnason I
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():30-2. PubMed ID: 9032580
[TBL] [Abstract][Full Text] [Related]
34. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
Hippisley-Cox J; Coupland C; Logan R
BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
[TBL] [Abstract][Full Text] [Related]
35. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
Feldman M; McMahon AT
Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
[No Abstract] [Full Text] [Related]
36. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract.
Bjarnason I; Thjodleifsson B
Rheumatology (Oxford); 1999 May; 38 Suppl 1():24-32. PubMed ID: 10369403
[TBL] [Abstract][Full Text] [Related]
37. [Selective COX-2 inhibitors for therapy of rheumatoid arthritis].
Sano H
Nihon Rinsho; 2005 Jan; 63 Suppl 1():477-87. PubMed ID: 15799403
[No Abstract] [Full Text] [Related]
38. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
Russell RI
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
[TBL] [Abstract][Full Text] [Related]
39. Meloxicam: selective COX-2 inhibition in clinical practice.
Furst DE
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):21-7. PubMed ID: 9219316
[TBL] [Abstract][Full Text] [Related]
40. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
